<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="168243">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02008799</url>
  </required_header>
  <id_info>
    <org_study_id>SCA2013</org_study_id>
    <nct_id>NCT02008799</nct_id>
  </id_info>
  <brief_title>Intra Testicular Artery Injection of Bone Marrow Stem Cell in Management of Azoospermia</brief_title>
  <official_title>Intra Testicular Artery Injection of Bone Marrow Stem Cell in Management of Azoospermia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Man Clinic for Andrology, Male Infertility and Sexual Dysfunction</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Man Clinic for Andrology, Male Infertility and Sexual Dysfunction</source>
  <oversight_info>
    <authority>Egypt: Ministry of Higher Education</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Azoospermia due to low sperm production (non-obstructive azoospermia) affects approximately
      1% of the male population and 10% of men who seek fertility evaluation. Testis biopsy
      reveals that these men have Sertoli cell-only pattern, maturation arrest, or
      hypospermatogenesis. Until recently, it was assumed that men with non-obstructive
      azoospermia were untreatable. Indeed, these patients were often referred to as being
      &quot;sterile&quot; or having &quot;testicular failure.&quot; We start to use stem cell in treatment of such
      patients by injecting the stem cell at the testis and the testicular artery in one group and
      at the testis only in other group
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">March 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Semen Analysis</measure>
    <time_frame>Three to six months</time_frame>
    <safety_issue>No</safety_issue>
    <description>After stem cell injection by three to six months we evaluate the outcome by semen analysis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Inhibin B Hormone</measure>
    <time_frame>Three to six months</time_frame>
    <safety_issue>No</safety_issue>
    <description>If semen analysis still azoo we do Inhibin B Hormone</description>
  </secondary_outcome>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Azoospermia</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Bone marrow stem cell injection</intervention_name>
    <description>Injection should be in testis and testicular artery</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - Azoospermia

        Exclusion Criteria:

        - Absent or surgical removed testes
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Khaled A Gadalla, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Man Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Khaled A Gadalla, MD</last_name>
    <phone>20222725025</phone>
    <email>Khaledgadalla@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Man Clinic</name>
      <address>
        <city>Cairo</city>
        <zip>33611</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Khaled A Gadalla, MD</last_name>
      <phone>20222725025</phone>
      <email>Khaledgadalla@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Khaled A Gadalla, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 8, 2013</lastchanged_date>
  <firstreceived_date>December 8, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Man Clinic for Andrology, Male Infertility and Sexual Dysfunction</investigator_affiliation>
    <investigator_full_name>Khaled Abdulmoneim Gadalla</investigator_full_name>
    <investigator_title>Prof Dr</investigator_title>
  </responsible_party>
  <keyword>Stem cell, infertility, Azoospermia</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Azoospermia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
